NCT04954885 2025-01-27
Evaluating Modifiable Biomarkers for the Prediction of Immunotherapy Response and Toxicity
Ohio State University Comprehensive Cancer Center
Completed
Ohio State University Comprehensive Cancer Center
Virginia Commonwealth University
Abramson Cancer Center at Penn Medicine
Memorial Sloan Kettering Cancer Center
University Hospital Southampton NHS Foundation Trust
Wake Forest University Health Sciences
University of East Anglia
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
St. Jude Children's Research Hospital
Freeman-Sheldon Research Group, Inc.